Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-04

Clinical Trial Results: Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, tolerability, PK, and food effect of MK-7762 in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK-7762 (MK-7762)

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED | Results posted: 2026-06-04